SWM
SeaCrest Wealth Management’s BioXcel Therapeutics BTAI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-11,150
| Closed | -$4.17K | – | 664 |
|
|
2024
Q4 | $4.17K | Sell |
11,150
-1,200
| -10% | -$449 | ﹤0.01% | 655 |
|
|
2024
Q3 | $7.53K | Sell |
12,350
-3,400
| -22% | -$2.07K | ﹤0.01% | 651 |
|
|
2024
Q2 | $20.2K | Sell |
15,750
-1,500
| -9% | -$1.92K | ﹤0.01% | 609 |
|
|
2024
Q1 | $48.6K | Sell |
17,250
-900
| -5% | -$2.54K | 0.01% | 596 |
|
|
2023
Q4 | $51K | Buy |
18,150
+1,600
| +10% | +$4.5K | 0.01% | 612 |
|
|
2023
Q3 | $41.9K | Sell |
16,550
-4,150
| -20% | -$10.5K | 0.01% | 614 |
|
|
2023
Q2 | $138K | Buy |
20,700
+5,793
| +39% | +$38.6K | 0.02% | 596 |
|
|
2023
Q1 | $278K | Buy |
+14,907
| New | +$278K | 0.04% | 485 |
|